Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 146
Immune Disorders Drugs 129
Central Nervous System Drugs 127
Biopharmaceuticals 88
Pharmaceuticals 86
Hematological Drugs 78
Vaccines 78
Clinical Trials 72
Drug Discovery 67
Cardiovascular Drugs 58
Infectious Diseases Drugs 58
Diabetes Drugs 56
Leukemia Drugs 52
Mental Disorders Drugs 45
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 40
Infusions and Injectables 33
Liver and Kidney Disorders Drugs 32
Over the Counter (OTC) Drugs 31
Lung Cancer Drugs 22
Pharmaceutical Manufacturing 20
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 19
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Prostate Cancer Drugs 12
Skin Cancer Drugs 12
Schizophrenia Drugs 12
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Uterine Cancer Drugs 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,647 Results (Page 35 of 83)
- Relevance
  Sort by

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1182 Pages
Global

From

€2204EUR$2,500USD£1,936GBP

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2204EUR$2,500USD£1,936GBP

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1699 Pages
Global

From

€2204EUR$2,500USD£1,936GBP

Graft Versus Host Disease (GvHD) Treatment - Global Strategic Business Report

 Report
December 2025
296 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

Granulocyte Macrophage Colony Stimulating Factor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
August 2024
92 Pages
Global

From

€3500EUR$4,253USD£3,182GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cabometyx (cabozantinib; Exelixis/Ipsen/Takeda) Drug Overview 2019

 Report
September 2019
29 Pages
Global

€8816EUR$10,000USD£7,743GBP

Ambroxol Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
116 Pages
Global

From

€3500EUR$4,253USD£3,182GBP

Lung Cancer Treatment Market - Global Strategic Business Report

 Report
December 2025
373 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
232 Pages
Global

From

€1763EUR$2,000USD£1,549GBP

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
628 Pages
Global

From

€2204EUR$2,500USD£1,936GBP

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
820 Pages
Global

From

€1763EUR$2,000USD£1,549GBP

Oncology Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

 Report
February 2024
146 Pages
Global

From

€3500EUR$4,253USD£3,182GBP

Recombinant Immunotherapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
113 Pages
Global

From

€3500EUR$4,253USD£3,182GBP

Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025

 Report
August 2025
1500 Pages +
Global

From

€4404EUR$4,995USD£3,868GBP

Cough Remedy - Global Strategic Business Report

 Report
December 2025
383 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

Bortezomib Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
72 Pages
Global

From

€3500EUR$4,253USD£3,182GBP

CAR-T Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
January 2024
174 Pages
Global

From

€3500EUR$4,253USD£3,182GBP

Pituitary Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
175 Pages
Global

From

€3967EUR$4,500USD£3,485GBP

North America Bone Cancer Treatment Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
122 Pages
North America

From

€3526EUR$4,000USD£3,097GBP

HPV Associated Disorders Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3958EUR$4,490USD£3,477GBP

1,647 Results (Page 35 of 83)
- 1
- 33
- 34
- 35
- 36
- 37

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.